Drug intelligence / Profile preview

flurandrenolide

Development stage
Approved
Lead developer
Almirall
Modality
Small Molecules
Administration
Topical
01

Overview

Flurandrenolide is a synthetic fluorinated corticosteroid used topically for its anti-inflammatory, antipruritic, and vasoconstrictive properties. It acts as an agonist at the glucocorticoid receptor, leading to the induction of phospholipase A2 inhibitory proteins, known as lipocortins. These proteins control the biosynthesis of potent mediators of inflammation, such as prostaglandins and leukotrienes, by inhibiting the release of their common precursor, arachidonic acid. Flurandrenolide is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, including eczematous dermatitis, psoriasis, and various forms of dermatitis. Originally developed by Eli Lilly under the brand name Cordran, it is available in several formulations including ointments, creams, lotions, and a unique medicated tape for sustained topical delivery.

Brand names
CordranCordran SPCordran Tape
Other names
flurandrenolone6alpha-fluoro-16alpha-hydroxyhydrocortisone 16,17-acetonide
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on flurandrenolide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flurandrenolide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call